These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 27544712)

  • 1. Predictive Properties of the Asthma Control Test and Its Component Questions for Severe Asthma Exacerbations.
    Cajigal S; Wells KE; Peterson EL; Ahmedani BK; Yang JJ; Kumar R; Burchard EG; Williams LK
    J Allergy Clin Immunol Pract; 2017; 5(1):121-127.e2. PubMed ID: 27544712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of a novel risk score for asthma exacerbations: The risk score for exacerbations.
    Bateman ED; Buhl R; O'Byrne PM; Humbert M; Reddel HK; Sears MR; Jenkins C; Harrison TW; Quirce S; Peterson S; Eriksson G
    J Allergy Clin Immunol; 2015 Jun; 135(6):1457-64.e4. PubMed ID: 25258144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Predictive factors associated with severity of asthma exacerbations].
    Atiş S; Kaplan ES; Ozge C; Bayindir S
    Tuberk Toraks; 2008; 56(2):187-96. PubMed ID: 18701979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Change in asthma control over time: predictors and outcomes.
    Schatz M; Zeiger RS; Yang SJ; Chen W; Crawford W; Sajjan S; Allen-Ramey F
    J Allergy Clin Immunol Pract; 2014; 2(1):59-64. PubMed ID: 24565770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of severe exacerbations, poor asthma control, and β-agonist overuse for patients with asthma.
    Patel M; Pilcher J; Reddel HK; Qi V; Mackey B; Tranquilino T; Shaw D; Black P; Weatherall M; Beasley R;
    J Allergy Clin Immunol Pract; 2014; 2(6):751-8. PubMed ID: 25439367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asthma exacerbation rates in adults are unchanged over a 5-year period despite high-intensity therapy.
    Schatz M; Meckley LM; Kim M; Stockwell BT; Castro M
    J Allergy Clin Immunol Pract; 2014; 2(5):570-4.e1. PubMed ID: 25213050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real life data on incidence and risk factors of severe asthma exacerbations in children in primary care.
    Engelkes M; Janssens HM; de Ridder MA; Sturkenboom MC; de Jongste JC; Verhamme KM
    Respir Med; 2016 Oct; 119():48-54. PubMed ID: 27692147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of future exacerbations in a multi-ethnic Asian population with asthma.
    Tay TR; Wong HS; Tee A
    J Asthma; 2019 Apr; 56(4):380-387. PubMed ID: 29688092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asthma control and severe exacerbations in patients with moderate or severe asthma in Jilin Province, China: a multicenter cross-sectional survey.
    Yan BD; Meng SS; Ren J; Lv Z; Zhang QH; Yu JY; Gao R; Shi CM; Wu CF; Liu CL; Zhang J; Ma ZS; Liu J
    BMC Pulm Med; 2016 Aug; 16(1):130. PubMed ID: 27577233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of risk factors and health outcomes among persons with asthma.
    Smith K; Warholak T; Armstrong E; Leib M; Rehfeld R; Malone D
    J Asthma; 2009 Apr; 46(3):234-7. PubMed ID: 19373629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term future risk of severe exacerbations: Distinct 5-year trajectories of problematic asthma.
    Yii ACA; Tan JHY; Lapperre TS; Chan AKW; Low SY; Ong TH; Tan KL; Chotirmall SH; Sterk PJ; Koh MS
    Allergy; 2017 Sep; 72(9):1398-1405. PubMed ID: 28295424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Factors influencing asthma course and the degree of control in the patients assessed with own questionnaire and Asthma Control Test (ACT)].
    Krasnodębska P; Hermanowicz-Salamon J; Domagała-Kulawik J; Chazan R
    Pneumonol Alergol Pol; 2012; 80(3):198-208. PubMed ID: 22562271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent asthma exacerbations: a key predictor of future exacerbations.
    Miller MK; Lee JH; Miller DP; Wenzel SE;
    Respir Med; 2007 Mar; 101(3):481-9. PubMed ID: 16914299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors hindering asthma symptom control in Saudi children and adolescents.
    Halwani R; Vazquez-Tello A; Horanieh N; Dulgom S; Al-Aseri Z; Al-Khamis N; Al-Sum Z; Al-Jahdali H; Al-Muhsen S
    Pediatr Int; 2017 Jun; 59(6):661-668. PubMed ID: 28218986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quarterly assessment of short-acting beta(2)-adrenergic agonist use as a predictor of subsequent health care use for asthmatic patients in the United States.
    Silver HS; Blanchette CM; Kamble S; Petersen H; Letter M; Meddis D; Gutierrez B
    J Asthma; 2010 Aug; 47(6):660-6. PubMed ID: 20615167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the National Heart, Lung, and Blood Institute guidelines impairment domain for classifying asthma control and predicting asthma exacerbations.
    Zeiger RS; Yegin A; Simons FE; Haselkorn T; Rasouliyan L; Szefler SJ; Chipps BE;
    Ann Allergy Asthma Immunol; 2012 Feb; 108(2):81-7. PubMed ID: 22289725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The frequency of asthma exacerbations and healthcare utilization in patients with asthma from the UK and USA.
    Suruki RY; Daugherty JB; Boudiaf N; Albers FC
    BMC Pulm Med; 2017 Apr; 17(1):74. PubMed ID: 28449686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying patients at risk for severe exacerbations of asthma: development and external validation of a multivariable prediction model.
    Loymans RJ; Honkoop PJ; Termeer EH; Snoeck-Stroband JB; Assendelft WJ; Schermer TR; Chung KF; Sousa AR; Sterk PJ; Reddel HK; Sont JK; Ter Riet G
    Thorax; 2016 Sep; 71(9):838-46. PubMed ID: 27044486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High blood eosinophil count is a risk factor for future asthma exacerbations in adult persistent asthma.
    Zeiger RS; Schatz M; Li Q; Chen W; Khatry DB; Gossage D; Tran TN
    J Allergy Clin Immunol Pract; 2014; 2(6):741-50. PubMed ID: 25439366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel endpoint for exacerbations in asthma to accelerate clinical development: a post-hoc analysis of randomised controlled trials.
    Fuhlbrigge AL; Bengtsson T; Peterson S; Jauhiainen A; Eriksson G; Da Silva CA; Johnson A; Sethi T; Locantore N; Tal-Singer R; Fagerås M
    Lancet Respir Med; 2017 Jul; 5(7):577-590. PubMed ID: 28583396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.